1. Home
  2. VSTM vs CYH Comparison

VSTM vs CYH Comparison

Compare VSTM & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • CYH
  • Stock Information
  • Founded
  • VSTM 2010
  • CYH 1985
  • Country
  • VSTM United States
  • CYH United States
  • Employees
  • VSTM N/A
  • CYH N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • CYH Hospital/Nursing Management
  • Sector
  • VSTM Health Care
  • CYH Health Care
  • Exchange
  • VSTM Nasdaq
  • CYH Nasdaq
  • Market Cap
  • VSTM 313.1M
  • CYH 375.1M
  • IPO Year
  • VSTM 2012
  • CYH 1991
  • Fundamental
  • Price
  • VSTM $5.82
  • CYH $2.59
  • Analyst Decision
  • VSTM Strong Buy
  • CYH Hold
  • Analyst Count
  • VSTM 8
  • CYH 7
  • Target Price
  • VSTM $13.00
  • CYH $4.10
  • AVG Volume (30 Days)
  • VSTM 882.3K
  • CYH 2.0M
  • Earning Date
  • VSTM 03-20-2025
  • CYH 04-23-2025
  • Dividend Yield
  • VSTM N/A
  • CYH N/A
  • EPS Growth
  • VSTM N/A
  • CYH N/A
  • EPS
  • VSTM N/A
  • CYH N/A
  • Revenue
  • VSTM $10,000,000.00
  • CYH $12,634,000,000.00
  • Revenue This Year
  • VSTM N/A
  • CYH N/A
  • Revenue Next Year
  • VSTM $867.23
  • CYH $4.08
  • P/E Ratio
  • VSTM N/A
  • CYH N/A
  • Revenue Growth
  • VSTM N/A
  • CYH 1.15
  • 52 Week Low
  • VSTM $2.10
  • CYH $2.53
  • 52 Week High
  • VSTM $13.52
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 41.02
  • CYH 37.33
  • Support Level
  • VSTM $5.68
  • CYH $2.72
  • Resistance Level
  • VSTM $6.89
  • CYH $2.85
  • Average True Range (ATR)
  • VSTM 0.49
  • CYH 0.13
  • MACD
  • VSTM -0.16
  • CYH 0.01
  • Stochastic Oscillator
  • VSTM 7.41
  • CYH 13.24

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: